DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Antisense therapy
Antisense therapy
Amyloid Seeding of Transthyretin by Ex Vivo Cardiac Fibrils and Its
Opportunities and Challenges for Antisense Oligonucleotide Therapies
Recent Advances in Oligonucleotide Therapeutics in Oncology
ALS Trial Shows Novel Therapy Is Safe | Newsroom | Washington University in St
(2018) ISSN 2541-108X I
Current Status of Microrna-Based Therapeutic Approaches in Neurodegenerative Disorders
Antisense Therapy for Cancer
Mutant Protein Spread in Huntington's Disease and Its Implications for Other Neurodegenerative Disorders of the CNS
Landscape Review and Evidence Map of Gene Therapy, Part 2
The Ins and Outs of Antisense Drugs
Eteplirsen in the Treatment of Duchenne Muscular Dystrophy
Antisense Therapy Potential Tool to Reduce Activity in MS Via Protein Expression Inhibition
Exondys 51 (Eteplirsen)
(12) Patent Application Publication (10) Pub. No.: US 2017/0173128A1 Hoge Et Al
Potential Opportunity of Antisense Therapy of Covid-19 on an in Vitro Model
Molecular Drug Targets and Therapies for Alzheimer's
In Vivo Bioavailability and Pharmacokinetics of a C-MYC Antisense Phosphorodiamidate Morpholino Oligomer, AVI-4126, in Solid Tumors Gayathri R
Huntingtin Lowering Strategies
Top View
Antisense Oligonucleotides and Other Genetic
Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
Tabrizi Huntingtin Lowering Strategies for Disease Modification
Antisense and Nuclear Medicine
The Future of Antisense Therapy: Combination with Anticancer Treatments
Cell, Gene, & RNA Therapy Landscape
Antisense Therapy Reverses Symptoms in Huntington Model, with Long-Term Benefi Ts Investigators Envision Clinical Trial Within Two Years
From Antisense RNA to RNA Modification
Therapeutic Strategies for Duchenne Muscular Dystrophy: an Update
Antisense Therapy, a Magic Bullet for the Treatment of Various Diseases: Present and Future Prospects
16 October 2019 Holiday Inn Munich - City Centre Munich, Germany Meeting Agenda As of October 16, 2019
Alzheimer's Disease
News Feature: Gene Therapy Successes Point to Better
Download Master-Thesis (PDF, 1
The Handbook of Neuroprotection
Lipoprotein(A)—Antisense Therapy
Eteplirsen in the Treatment of Duchenne Muscular Dystrophy
Assisted Delivery of Antisense Therapeutics in Animal
Mechanistic Principles of Antisense Targets for the Treatment of Spinal Muscular Atrophy Natalia N
Current Developments in Gene Therapy for Amyotrophic Lateral Sclerosis
Cell-Based Therapies for Huntington's Disease Yiju Chen, Emory University Richard L
Therapies Targeting DNA and RNA in Huntington's Disease
Spinal Muscular Atrophy Pipeline Awaits Nusinersen News
Antisense Therapy in Neurology
A Simple Method for Delivering Morpholino Antisense Oligos Into the Cytoplasm of Cells
Rnai Mechanisms in Huntington's Disease Therapy: Sirna Versus
Promising Therapy for ALS Delivers Antisense Drug Directly To
Antisense Cancer Therapy
Biogen and Ionis Report Positive Topline Clinical Data on Investigational Alzheimer's Disease Treatment at AAIC
Document Nda 206488
Advances in Ionis' Novel Antisense Technology to Be Presented at 2018 Society for Neuroscience Meeting
Ionis Licenses Investigational Alzheimer's Therapy
Antisense Oligonucleotides Therapy in the Treatment of Cerebral
18Jan2017-Oig-Investigation-Request
VIEW Open Access the Potential of Antisense Oligonucleotide Therapies for Inherited Childhood Lung Diseases Kelly M
Briefing Document – COST and SCOPE-DMD EMA Meeting
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases